KA McNeill. Epidemiology of brain tumors. Neurol Clin. 2016, 34(4): 981-998.
JM Hoover, M Nwojo, R Puffer, et al. Surgical outcomes in recurrent glioma: clinical article. J Neurosurg. 2013, 118(6): 1224-1231.
SL Hervey-Jumper, MS Berger. Reoperation for recurrent high-grade glioma: a current perspective of the literature. Neurosurgery. 2014, 75(5): 491-499.
C Jackson, M Westphal, A Quiñones-Hinojosa. Complications of glioma surgery. Handb Clin Neurol. 2016, 134: 201-218.
ER Laws, IF Parney, W Huang, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003, 99(3): 467-473.
CG Patil, A Yi, A Elramsisy, et al. Prognosis of patients with multifocal glioblastoma: a case-control study. J Neurosurg. 2012, 117(4): 705-711.
MI Ruge, J Ilmberger, JC Tonn, et al. Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol. 2011, 103(1): 129-136.
LB Chambless, HM Kistka, SL Parker, et al. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme. J Neurooncol. 2015, 121(2): 359-364.
JKW Gerritsen, L Arends, M Klimek, et al. Impact of intraoperative stimulation mapping on high-grade glioma surgery outcome: a meta-analysis. Acta Neurochir (Wien). 2019, 161(1): 99-107.
LB Chambless, SL Parker, L Hassam-Malani, et al. Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high- grade glioma. J Neurooncol. 2012, 106(2): 383-389.
RS D’Amico, MB Cloney, AM Sonabend, et al. The safety of surgery in elderly patients with primary and recurrent glioblastoma. World Neurosurg. 2015, 84(4): 913-919.
HH Dasenbrock, KX Liu, CA Devine, et al. Length of hospital stay after craniotomy for tumor: a national surgical quality improvement program analysis. Neurosurg Focus. 2015, 39(6): E12.
B Idali, B Lahyat, K Khaleq, et al. Postoperative infection following craniotomy in adults. Med Mal Infect. 2004, 34(5): 221-224.
BA Sherrod, JM Johnston, BG Rocque. Risk factors for unplanned readmission within 30 days after pediatric neurosurgery: a nationwide analysis of 9799 procedures from the American college of surgeons national surgical quality improvement program. J Neurosurg Pediatr. 2016, 18(3): 350-362.
A Nunno, Y Li, TA Pieters, et al. Risk factors and associated complications of symptomatic venous thromboembolism in patients with craniotomy for meningioma. World Neurosurg. 2019, 122: e1505-e1510.
JM Wong, JR Panchmatia, JE Ziewacz, et al. Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurg Focus. 2012, 33(5): E16.
E Reponen, M Korja, T Niemi, et al. Preoperative identification of neurosurgery patients with a high risk of in-hospital complications: a prospective cohort of 418 consecutive elective craniotomy patients. J Neurosurg. 2015, 123(3): 594-604.
E Jiménez-Martínez, G Cuervo, A Hornero, et al. Risk factors for surgical site infection after craniotomy: a prospective cohort study. Antimicrob Resist Infect Control. 2019, 8: 69.
DN Louis, A Perry, G Reifenberger, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016, 131(6): 803-820.
AJ Clark, KR Lamborn, NA Butowski, et al. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery. 2012, 70(2): 361-370.
HJ Landy, L Feun, JG Schwade, et al. Retreatment of intracranial gliomas. South Med J. 1994, 87(2): 211-214.